Electra Therapeutics, Inc. (ETRA) Stock
Electra Therapeutics, Inc. is a clinical stage biotechnology company.
Valuation
Financials & Margins
Ownership
About Electra Therapeutics, Inc.
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.
Electra Therapeutics, Inc. is headquartered in US.
Electra Therapeutics, Inc. (ETRA) stock trades at $8.71 with a market capitalization of $184.76M. The stock is valued at a negative price-to-earnings (P/E) ratio of -3.25, reflecting a net loss over the last twelve months. Over the past 52 weeks the stock has ranged between $8.50 and $15.50, and currently trades 43.8% below its 52-week high.
Official website: www.electra-therapeutics.com
Electra Therapeutics, Inc. (ETRA) — frequently asked questions
What is Electra Therapeutics, Inc. (ETRA) stock price today?
Electra Therapeutics, Inc. (ETRA) is currently trading at $8.71, down 5.84% today.
What is ETRA P/E ratio?
Electra Therapeutics, Inc.'s P/E ratio is -3.25. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is Electra Therapeutics, Inc.'s market cap?
Electra Therapeutics, Inc. has a market capitalization of $184.76M.
Does ETRA pay a dividend?
Electra Therapeutics, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does ETRA carry?
Electra Therapeutics, Inc. has a debt-to-equity ratio of 0.02. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is ETRA's profit margin?
Electra Therapeutics, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is ETRA in?
Electra Therapeutics, Inc. is classified under Healthcare, in the Medical - Pharmaceuticals industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is ETRA listed on?
Electra Therapeutics, Inc. trades on NASDAQ under the ticker ETRA.
What is ETRA's 52-week range?
Over the last year Electra Therapeutics, Inc. has traded between $8.50 and $15.50.
Related Healthcare Stocks
Popular Stocks
Screens ETRA currently matches
On the figures above, Electra Therapeutics, Inc. passes the filters for 4 of our ready-made screens, among them Day Losers Stocks, Debt Free Stocks Under $100, Micro Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.